Pemigatinib (INCB054828)
CAS: 1513857-77-6
Ref. 3D-NKC85777
| 1mg | Nachfragen | ||
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Produktinformation
Pemigatinib is a potent inhibitor of FGFR2 kinase, which is an enzyme involved in the cell signaling pathways that regulate cell growth and differentiation. Pemigatinib has been shown to inhibit the growth of cancer cells in vitro and in animal models. It also inhibits the proliferation of myeloid leukemia cells by inhibiting the MAPK/ERK and PI3K/AKT signaling pathways, as well as cancer-associated fibroblasts. Pemigatinib has been shown to have activity against infectious diseases such as hepatitis C virus (HCV) infection, with inhibition of HCV replication in vitro. The drug also induces apoptosis in cholangiocarcinoma cells by inhibiting protein synthesis.
Pemigatinib is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase,
Chemische Eigenschaften
Technische Anfrage zu: 3D-NKC85777 Pemigatinib (INCB054828)
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
